AMN1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.312000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.623000E-01
Normal-vs-Stage2
3.141600E-01
Normal-vs-Stage3
3.074000E-01
Normal-vs-Stage4
6.947400E-01
Stage1-vs-Stage2
6.386000E-01
Stage1-vs-Stage3
2.833400E-01
Stage1-vs-Stage4
8.818400E-01
Stage2-vs-Stage3
5.924400E-01
Stage2-vs-Stage4
6.055800E-01
Stage3-vs-Stage4
2.947000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.738600E-01
Normal-vs-AfricanAmerican
3.118200E-01
Normal-vs-Asian
3.544400E-01
Caucasian-vs-AfricanAmerican
4.950400E-01
Caucasian-vs-Asian
1.179840E-02
AfricanAmerican-vs-Asian
5.176200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.289200E-01
Normal-vs-Female
5.567200E-01
Male-vs-Female
7.544400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.164400E-01
Normal-vs-Age(41-60Yrs)
7.309600E-01
Normal-vs-Age(61-80Yrs)
4.951000E-01
Normal-vs-Age(81-100Yrs)
4.362400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.922400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.601800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.086000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.682400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.175600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.558000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.864840E-01
Normal-vs-Daily Drinker
6.152000E-01
Normal-vs-Weekly Drinker
1.333190E-01
Normal-vs-Occasional Drinker
6.794600E-01
Normal-vs-Social Drinker
7.346600E-01
Non Drinker-vs-Daily Drinker
7.272600E-01
Non Drinker-vs-Weekly Drinker
4.355800E-01
Non Drinker-vs-Occasional Drinker
3.185600E-02
Non Drinker-vs-Social Drinker
3.192800E-01
Daily Drinker-vs-Weekly Drinker
4.336600E-01
Daily Drinker-vs-Occasional Drinker
8.571600E-02
Daily Drinker-vs-Social Drinker
6.514400E-01
Weekly Drinker-vs-Occasional Drinker
1.676320E-02
Weekly Drinker-vs-Social Drinker
1.618030E-01
Occasional Drinker-vs-Social Drinker
1.979620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.955240E-01
Normal-vs-Grade 2
4.216000E-02
Normal-vs-Grade 3
1.103610E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.002300E-02
Grade 1-vs-Grade 3
2.930600E-01
Grade 1-vs-Grade 4
1.955240E-01
Grade 2-vs-Grade 3
7.591600E-02
Grade 2-vs-Grade 4
4.216000E-02
Grade 3-vs-Grade 4
1.103610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.124400E-01
Normal-vs-NonDiabetic
6.745400E-01
Diabetic-vs-NonDiabetic
1.688000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.958800E-01
Normal-vs-NoPancreatitis
5.763400E-01
Pancreatitis-vs-NoPancreatitis
4.202600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.019000E-01
Normal-vs-N1
2.937400E-01
N0-vs-N1
5.405700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.994000E-01
Normal-vs-TP53-NonMutant
9.812400E-01
TP53-Mutant-vs-TP53-NonMutant
3.240400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
